Neurogene NGNE
NASDAQ NGNE
$26.55 -1.27 (-4.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Neurogene (NGNE) Preferred Dividend Payments (2013 - 2014)

Updated

Neurogene (NGNE) posted Preferred Dividend Payments of $13,000 for FY2014, down 89.4% from $123,074 in FY2013.

Analysis

Neurogene (NGNE) Preferred Dividend Payments (2013 - 2014) Analysis & Trends

  • Business Quant data shows NGNE's Preferred Dividend Payments at $123,074 in FY2013 (-27.0%) and $168,702 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Neurogene 627.40 Mn 627.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 1.00
Mar 31, 2014 19,550.00
Jun 30, 2013 42,130.00
Mar 31, 2013 44,307.00
API Access

Neurogene Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=NGNE&period=max&api_key=YOUR_API_KEY